Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kenvue Inc. Common Stock (NY:KVUE)

16.30 +0.33 (+2.04%)
Streaming Delayed Price Updated: 2:13 PM EST, Nov 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Kenvue Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Kenvue (KVUE) Plunges Amidst Dual Headwinds: Tylenol Fears and Escalating Talc Litigation
Kenvue (NYSE: KVUE), the consumer health giant spun off from Johnson & Johnson, has found itself at the bottom of today's market performance, with its stock price experiencing a significant decline. As... 
Via MarketMinute
Topics Government Lawsuit
Discover which S&P500 stocks are making waves on Thursday.
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Thursday. 
Via Chartmill
These S&P500 stocks are the most active in today's session
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention. 
Via Chartmill
Kenvue Stock To Face More Headwinds? Trump’s Tylenol Warning Revives Autism Lawsuits, Retail Bulls Stay Unfazed
Via Stocktwits
Topics Government Lawsuit
What's going on in today's session: S&P500 movers
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session. 
Via Chartmill
Johnson & Johnson, Kenvue Named In First Ever UK Legal Action Over Talc Cancer Claims
Johnson & Johnson faces 3,000 UK lawsuits alleging asbestos-contaminated talcum powder caused cancer and concealed risks for decades. 
Via Benzinga
Topics Lawsuit
Johnson & Johnson Battles New UK Talc Cancer Claims Worth £1B After Massive US Verdict: Report
Meanwhile, analysts raised price targets on the stock following strong Q3 results and the planned orthopedic spin-off. 
Via Stocktwits
Topics Bankruptcy Death Lawsuit
2 Ultra-High-Yield Dividend Stocks With Total Return Potential of Up to 41% in 12 Months, According to Select Wall Street Analysts
Juicy dividends are only part of the attraction with these beaten-down stocks. 
Via The Motley Fool
Topics Government
Albert Invent Partners with Kenvue to Build the Future of Consumer Health Products With the Help of AI
From Albert Invent
Via Business Wire
These S&P500 stocks are moving in today's session
Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session. 
Via Chartmill
Johnson & Johnson Q3 Preview: With Stock Near All-Time Highs, Here's What To Watch
Johnson & Johnson stock trades near all-time highs with an upcoming Q3 earnings report acting as the next catalyst. 
Via Benzinga
Tylenol Turmoil: Partisan Politics Fuel Confusion Over Pregnancy Risks, Poll Shows
KFF poll shows falling trust in the CDC and HHS chief RFK Jr. as misinformation and partisan divides shape public views on vaccines. 
Via Benzinga
Is This Beaten-Down Dividend King a Buy?
This company's short life on the stock market has been a constant challenge. 
Via The Motley Fool
Topics Intellectual Property
Which S&P500 stocks are moving on Thursday?
Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive... 
Via Chartmill
Stocks Ease, Delta Air Lines, Pepsi Jump On Strong Earnings: What's Moving Markets Thursday?
U.S. stocks edged lower on Thursday, pausing after a record-setting run. The S&P 500 slipped 0.4% by midday in New York, retreating from an all-time high of 5,674 hit at the open. 
Via Benzinga
Discover which S&P500 stocks are making waves on Thursday.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday. 
Via Chartmill
These Were the 5 Worst-Performing Stocks in the S&P 500 in September 2025 -- and One's Decline Can Be Tied to President Trump
One of these stocks lost about a quarter of its value in a single month. 
Via The Motley Fool
Topics Government Stocks World Trade
Near 52-Week Low, Should You Buy Kenvue Stock?
This beaten-down stock could be an attractive option for long-term investors. 
Via The Motley Fool
Discover which S&P500 stocks are making waves on Tuesday.
Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
Stocks, Bitcoin Slip, Gold Hits $4,000: What's Moving Markets Tuesday?
Risk sentiment is taking a breather after days of a relentless rally, with all major Wall Street indexes trading in negative territory and sharper declines hitting the most speculative assets, such as... 
Via Benzinga
Exploring the top movers within the S&P500 index during today's session.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Tuesday. 
Via Chartmill
Why Is Kenvue Stock Falling, and Is It a Buying Opportunity?
Investors are interested in this beaten-down business. 
Via The Motley Fool
Options Corner: Despite Political Woes, Kenvue Can Still Make Tylenol Great Again
While Kenvue's Tylenol has attracted intense political pressure, speculators are determined to make KVUE stock great again. 
Via Benzinga
A Congress Member Sold Up To $330K In UnitedHealth Group Stock: Here's What You Need To Know
 
Via Benzinga
Should You Buy Kenvue Stock After Its 30% Plunge?
There hasn't been much good news lately for this Johnson & Johnson spinoff. 
Via The Motley Fool
Topics Government Lawsuit
Cullen Trims KVUE Stake With $149.5M Share Sale
Via The Motley Fool
Topics Regulatory Compliance
Friday's session: most active stock in the S&P500 index
Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Friday and discover the stocks that are dominating the trading activity and setting the pace for... 
Via Chartmill
Demystifying Kenvue: Insights From 11 Analyst Reviews
Kenvue (NYSE: KVUE) underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. In the table below, you'll find a summary of their recent ratings,... 
Via Benzinga
White House Highlights A Controversial 2017 Tylenol Tweet On Its Usage During Pregnancy: 'We Actually Don't Recommend...'
A 2017 post by Tylenol on X (formerly Twitter) highlighted by White House has fueled a buzz around President Donald Trump‘s claim that the drug is linked with autism in kids. 
Via Benzinga
Kenvue Bounces Off Record Low: A Deep Dive into its Rebound and Future Prospects
Kenvue (NYSE: KVUE), the consumer health giant spun off from Johnson & Johnson, has experienced a significant rebound in its stock price, climbing notably from a recent record low. This resurgence... 
Via MarketMinute
Topics Government Product Recall
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.